The starting dose is typically 2.5 mg, with gradual titration every four weeks to minimize gastrointestinal side effects and improve tolerability
However, the elasticity index values measured with the Triplesense TR-3 did not differ significantly between the sites that received GSSG and those that received placebo (data not shown)
Ultimately, the decision between the two would involve a discussion with your healthcare provider, considering individual needs, cardiometabolic profile, preferences, and potential side effects
When this happens, the medication may not interact with the bodys receptors the way it was designed to
Fourth, we could not adjust the effect of glycosylated hemoglobin A1c and glycemic control in our population-based study due to the lacking of this information in our database